Chemokines in vasculitis.

The systemic vasculitides are a group of diseases where the primary pathological process is inflammatory injury to blood vessel walls. Their clinical manifestations are highly variable and range from organ specific disease to a systemic illness that can lead, if untreated, to multi-organ failure and death. The kidneys are often involved in systemic vasculitis, particularly in small vessel vasculitis, where the glomerular capillary bed is a target for injury. This leads to a vasculitic glomerulonephritis, with focal segmental inflammation and perivascular leukocyte accumulation evolving to extracapillary accumulation of mononuclear cells (including crescents). The kinetics of leukocyte infiltration and involvement in this setting are in part dependent on the combinatorial expression of chemokines and their receptors. We discuss the evidence base for the role of the chemokine network in the renal disease of small vessel vasculitis and extend this to non-renal aspects of small vessel vasculitis other systemic vasculitides.

[1]  A. Howie Handbook of Renal Biopsy Pathology , 2020, Springer Netherlands.

[2]  R. Welch,et al.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease , 2007, Clinical and experimental immunology.

[3]  B. Fevang,et al.  Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation. , 2007, Rheumatology.

[4]  U. Panzer,et al.  Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. , 2007, Journal of the American Society of Nephrology : JASN.

[5]  M. Adachi,et al.  Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. , 2006, Arthritis and rheumatism.

[6]  Sanjay Jain,et al.  Role of C-C chemokines in Takayasu's arteritis disease. , 2006, International journal of cardiology.

[7]  M. Kretzler,et al.  Expression of the chemokine receptor CXCR1 in human glomerular diseases. , 2006, Kidney international.

[8]  R. Falk,et al.  Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. , 2006, Journal of the American Society of Nephrology : JASN.

[9]  S. Nourshargh,et al.  Intravital microscopy in the study of ANCA-associated systemic vasculitis. , 2005, Clinical nephrology.

[10]  S. Jalkanen,et al.  Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. , 2005, Journal of the American Society of Nephrology : JASN.

[11]  S. Nourshargh,et al.  Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. , 2005, Blood.

[12]  S. Frøland,et al.  Increased expression of chemokines in patients with Wegener's granulomatosis − modulating effects of methylprednisolone in vitro , 2005, Clinical and experimental immunology.

[13]  M. Rastaldi,et al.  Histopathological atlas of renal diseases: ANCA-associated vasculitis (Second part). , 2005, Journal of nephrology.

[14]  C. Savage,et al.  ANCA induces β2 integrin and CXC chemokine‐dependent neutrophil‐endothelial cell interactions that mimic those of highly cytokine‐activated endothelium , 2005, Journal of leukocyte biology.

[15]  C. Kallenberg,et al.  Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  J. Wieslander,et al.  Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome? , 2004, Mediators of inflammation.

[17]  M. Bértolo,et al.  Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet’s disease , 2004, Clinical Rheumatology.

[18]  C. Cohen,et al.  CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. , 2004, The American journal of pathology.

[19]  T. Tedder,et al.  Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis , 2004, The Journal of experimental medicine.

[20]  J. Miyazaki,et al.  Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. , 2003, Arthritis and rheumatism.

[21]  B. Yard,et al.  SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits. , 2003, Kidney international.

[22]  Deren Huang,et al.  Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. , 2003, The Journal of rheumatology.

[23]  W. Thomson,et al.  Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. , 2002, The Journal of rheumatology.

[24]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[25]  C. Alpers,et al.  Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. , 2002, Kidney international.

[26]  L. Kamesh,et al.  ANCA-positive vasculitis. , 2002, Journal of the American Society of Nephrology : JASN.

[27]  C. Savage,et al.  New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis , 2002, Current opinion in rheumatology.

[28]  P. Cockwell,et al.  Fractalkine expression in human renal inflammation , 2002, The Journal of pathology.

[29]  C. Savage,et al.  Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. , 2001, Arthritis and rheumatism.

[30]  A. Howie,et al.  Potential role for monocyte chemotactic protein‐4 (MCP‐4) in monocyte/macrophage recruitment in acute renal inflammation , 2001, The Journal of pathology.

[31]  K. Matsushima,et al.  Upregulation of Fractalkine in Human Crescentic Glomerulonephritis , 2001, Nephron.

[32]  C. Alpers,et al.  J Am Soc Nephrol 11: 2231–2242, 2000 Expression of the Chemokine Monocyte Chemoattractant Protein-1 and Its Receptor Chemokine Receptor 2 in Human , 2022 .

[33]  K. Stengaard-Pedersen,et al.  Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica , 2000, Annals of the rheumatic diseases.

[34]  M. Mack,et al.  The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. , 2000, Kidney international.

[35]  P. Cockwell,et al.  Role of Leukocytes in the Immunopathogenesis of ANCA-Associated Glomerulonephritis , 2000, Nephron.

[36]  A. Wiik,et al.  Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. , 2000, Kidney international.

[37]  M. Salvadori,et al.  Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. , 1999, Journal of the American Society of Nephrology : JASN.

[38]  K. Matsushima,et al.  MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. , 1999, Kidney international.

[39]  M. Mack,et al.  Expression of the C-C chemokine receptor 5 in human kidney diseases. , 1999, Kidney international.

[40]  D. Adu,et al.  Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 1999, Kidney international.

[41]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[42]  A. Howie,et al.  In situ analysis of C-C chemokine mRNA in human glomerulonephritis. , 1998, Kidney international.

[43]  D. Lo,et al.  In Vivo Inhibition of CC and CX3C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II , 1998, The Journal of experimental medicine.

[44]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[45]  R. Falk,et al.  Small-vessel vasculitis. , 1997, The New England journal of medicine.

[46]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[47]  C. Marsh,et al.  Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. , 1997, The Journal of clinical investigation.

[48]  V. Tesar,et al.  Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[50]  P. Hiemstra,et al.  Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. , 1996, Journal of the American Society of Nephrology : JASN.

[51]  R. Porter Nomenclature of Systemic Vasculitides: Proposal of an International Consensus Conference , 1995 .

[52]  B. Rovin,et al.  Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[53]  C. Kallenberg,et al.  Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. , 1994, Kidney international.

[54]  F. Thaiss,et al.  Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. , 2006, Journal of the American Society of Nephrology : JASN.

[55]  D. Adu,et al.  ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation. , 2005, Kidney international.

[56]  井上 淳 Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice , 2005 .

[57]  S. Nityanand,et al.  Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity. , 2004, Clinical and experimental rheumatology.

[58]  M. Salvadori,et al.  IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. , 2002, Journal of the American Society of Nephrology : JASN.

[59]  古市 賢吾 Distinct Expression of CCR1 and CCR5 in Glomerular and Interstitial Lesions of Human Glomerular Diseases , 2000 .

[60]  L. Gesualdo,et al.  Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. , 1997, Kidney international.

[61]  F. Luft,et al.  Circulating leukocyte integrin expression in Wegener's granulomatosis. , 1996, Journal of the American Society of Nephrology : JASN.

[62]  M. Daha,et al.  Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. , 1995, Clinical nephrology.

[63]  L. Noel,et al.  Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. , 1993, The Quarterly journal of medicine.

[64]  T. Risler,et al.  Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.